P/B
—
Bausch Health Companies
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
$2.2B
Market Cap • 10/5/2026
1994
(32 years)
Founded
1994
(32 years ago)
IPO
NYSE
Listing Exchange
Canada
Country
Valuation
P/S
0,2
P/EBITDA
1,1
P/OCF
1,6
P/FCF
1,9
P/E
—
BVPS
—
EPS
—
Market Cap
Market Cap
2,2B
EV
22,1B
EV/Revenue
1,8
EV/EBITDA
11,5
EV/EBIT
20,4
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
0%
Total Yield
0%
Payout
0%
Retained Earnings
-10,8B
Profitability
Gross Margin
71,6%
EBITDA Margin
15,8%
EBIT Margin
8,9%
Net Margin
—
D&A/EBITDA
57%
R&D/Revenue
6,1%
Capex/Revenue
2,1%
Capex/D&A
30,9%
Capex/OCF
18,4%
SBC/OCF
12,3%
% PPE
8,5%
% Goodwill
39,5%
ROE
330,1%
ROIC
2,4%
Growth
CAGR Revenue 5Y
7,6%
CAGR Net Income 5Y
-3,4%
CAGR EPS 5Y
11,4%
CAGR OCF 5Y
-0,9%
Leverage
N.D./EBITDA
9,8
Debt/Equity
0%
Current Ratio
1,4
Quick Ratio
0,9
Interest Coverage
59,3%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!